DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) was the recipient of a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 54,100 shares, an increase of 14.6% from the December 31st total of 47,200 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 541.0 days.
Analysts Set New Price Targets
Separately, UBS Group downgraded shares of DiaSorin from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 26th.
Get Our Latest Stock Analysis on DiaSorin
DiaSorin Stock Performance
DiaSorin Company Profile
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
See Also
- Five stocks we like better than DiaSorin
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.